Literature DB >> 21769624

[Treating ICD patients at the end of their lives: attitudes, knowledge, and behavior of doctors and patients. A critical literature analysis].

K-H Ladwig1, N F Ischinger, J Ronel, C Kolb.   

Abstract

BACKGROUND: The implantable cardioverter-defibrillator (ICD) is highly effective in the therapy of malign heart rhythm abnormalities. However, the ethical dilemma of harming a dying patient has received little attention. We studied the current state of knowledge and behavior of physicians and the subjective needs of ICD patients with respect to end-of-life issues.
METHODS: A literature search of articles published between 8/2010 and 3/2011 in PubMed resulted in the identification of 32 reports, of which 25 met selection criteria.
RESULTS: Practically no clinical institution (96% in Europe) offers routine counseling of ICD patients on end-of-life issues. In only about 25% of cases do doctors initiate a discussion on this issue with the ICD patient, of which the majority takes place during the final hours of the patient's life. Knowledge of legal aspects of ICD deactivation is insufficient in about 50% of physicians. Many physicians underestimate the impact of ICD shocks and often have unrealistic expectations about the patient's knowledge on technical aspects of the ICD device. The majority of patients are reluctant to address this topic and prefer to rely on the decision of their attending physician.
CONCLUSION: Despite insufficient empirical data, findings point to a low willingness of ICD patients to confront the end-of-life issue and prefer decisions to be made by their physician. Substantial knowledge gaps of physicians may cause barriers in considering the option of deactivating the ICD.

Entities:  

Mesh:

Year:  2011        PMID: 21769624     DOI: 10.1007/s00399-011-0138-x

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN: 0938-7412


  27 in total

1.  Withdrawing implantable defibrillator shock therapy in terminally ill patients.

Authors:  William R Lewis; Donna L Luebke; Nancy J Johnson; Michael D Harrington; Ottorino Costantini; Mark P Aulisio
Journal:  Am J Med       Date:  2006-10       Impact factor: 4.965

2.  The shift of residents from university to non-university hospitals in Japan: a survey study.

Authors:  Kyoko Nomura; Eiji Yano; Shunsaku Mizushima; Hiroyoshi Endo; Makoto Aoki; Hideo Shinozaki; Tsuguya Fukui
Journal:  J Gen Intern Med       Date:  2008-07       Impact factor: 5.128

3.  Implantable cardioverter-defibrillator deactivation at the end of life: a physician survey.

Authors:  Amy S Kelley; M Carrington Reid; David H Miller; Joseph J Fins; Mark S Lachs
Journal:  Am Heart J       Date:  2009-02-23       Impact factor: 4.749

4.  ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons.

Authors:  Andrew E Epstein; John P DiMarco; Kenneth A Ellenbogen; N A Mark Estes; Roger A Freedman; Leonard S Gettes; A Marc Gillinov; Gabriel Gregoratos; Stephen C Hammill; David L Hayes; Mark A Hlatky; L Kristin Newby; Richard L Page; Mark H Schoenfeld; Michael J Silka; Lynne Warner Stevenson; Michael O Sweeney; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Christopher E Buller; Mark A Creager; Steven M Ettinger; David P Faxon; Jonathan L Halperin; Loren F Hiratzka; Sharon A Hunt; Harlan M Krumholz; Frederick G Kushner; Bruce W Lytle; Rick A Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Lynn G Tarkington; Clyde W Yancy
Journal:  Circulation       Date:  2008-05-15       Impact factor: 29.690

5.  Ethical and legal views of physicians regarding deactivation of cardiac implantable electrical devices: a quantitative assessment.

Authors:  Daniel B Kramer; Aaron S Kesselheim; Dan W Brock; William H Maisel
Journal:  Heart Rhythm       Date:  2010-07-19       Impact factor: 6.343

6.  Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).

Authors:  Jonathan P Piccini; Sana M Al-Khatib; Anne S Hellkamp; Kevin J Anstrom; Jeanne E Poole; Daniel B Mark; Kerry L Lee; Gust H Bardy
Journal:  Heart Rhythm       Date:  2010-11-23       Impact factor: 6.343

7.  Brief communication: Management of implantable cardioverter-defibrillators in hospice: A nationwide survey.

Authors:  Nathan Goldstein; Melissa Carlson; Elayne Livote; Jean S Kutner
Journal:  Ann Intern Med       Date:  2010-03-02       Impact factor: 25.391

8.  Deactivation of implanted cardioverter-defibrillators at the end of life: results of the EHRA survey.

Authors:  Germanas Marinskis; Lieselot van Erven
Journal:  Europace       Date:  2010-08       Impact factor: 5.214

9.  Dying and defibrillation: a shocking experience.

Authors:  Vinod Nambisan; David Chao
Journal:  Palliat Med       Date:  2004-07       Impact factor: 4.762

10.  Barriers to conversations about deactivation of implantable defibrillators in seriously ill patients: results of a nationwide survey comparing cardiology specialists to primary care physicians.

Authors:  Nathan Goldstein; Elizabeth Bradley; Jessica Zeidman; Davendra Mehta; R Sean Morrison
Journal:  J Am Coll Cardiol       Date:  2009-07-21       Impact factor: 24.094

View more
  1 in total

1.  Position paper on the importance of psychosocial factors in cardiology: Update 2013.

Authors:  Karl-Heinz Ladwig; Florian Lederbogen; Christian Albus; Christiane Angermann; Martin Borggrefe; Denise Fischer; Kurt Fritzsche; Markus Haass; Jochen Jordan; Jana Jünger; Ingrid Kindermann; Volker Köllner; Bernhard Kuhn; Martin Scherer; Melchior Seyfarth; Heinz Völler; Christiane Waller; Christoph Herrmann-Lingen
Journal:  Ger Med Sci       Date:  2014-05-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.